No major changes to Lilly sales force: Taurel

Share this article:
Eli Lilly CEO Sidney Taurel said the company does not plan any major changes to the size of its sales force, even as rivals cut jobs. “We won’t grow our sales force,” Taurel told cable network CNBC. “There has been some reduction…of our sales force. But we don’t see major decreases.” Taurel said Lilly has already decreased its total work force by 4,500, or 10%, since the middle of 2004. Late last year, Pfizer announced cuts to its US and European sales forces by at least 20%. And AstraZeneca said earlier this month it plans to cut 3,000 jobs, or 4.6% of its workforce.
Share this article:
You must be a registered member of MMM to post a comment.


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.